Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs
暂无分享,去创建一个
Q. Dou | T. Chan | S. Wan | J. Kanwar | T. Mujtaba
[1] S. Kaufmann,et al. Noxa/Bcl-2 Protein Interactions Contribute to Bortezomib Resistance in Human Lymphoid Cells* , 2011, The Journal of Biological Chemistry.
[2] Di Chen,et al. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors. , 2010, International journal of molecular medicine.
[3] R. Mazroui,et al. The chemotherapeutic agent bortezomib induces the formation of stress granules , 2010, Cancer Cell International.
[4] B. Sarg,et al. GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. , 2009, Blood.
[5] Thomas C. Chen,et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. , 2009, Blood.
[6] B. Aggarwal,et al. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model , 2009, Molecular Cancer Therapeutics.
[7] B. Kim,et al. Curcumin in combination with bortezomib synergistically induced apoptosis in human multiple myeloma U266 cells , 2008, Molecular oncology.
[8] G. Peters,et al. Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. , 2008, Blood.
[9] Sanjeev Banerjee,et al. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. , 2008, Cancer research.
[10] K. Young,et al. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma , 2008, Molecular Cancer.
[11] R. Planalp,et al. Curcumin: From ancient medicine to current clinical trials , 2008, Cellular and Molecular Life Sciences.
[12] Di Chen,et al. Inhibition of the proteasome activity by gallium(III) complexes contributes to their anti prostate tumor effects. , 2007, Cancer research.
[13] K. Anderson,et al. Gene expression analysis of B‐lymphoma cells resistant and sensitive to bortezomib * , 2006, British journal of haematology.
[14] A. D’Andrea,et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway , 2006, Molecular Cancer Therapeutics.
[15] P. Poma,et al. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. , 2005, Cancer letters.
[16] L. Chow,et al. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells. , 2005, Frontiers in bioscience : a journal and virtual library.
[17] D. Karunagaran,et al. Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization* , 2005, Journal of Biological Chemistry.
[18] M. Borad,et al. The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.